226
Views
8
CrossRef citations to date
0
Altmetric
Research Articles

Development of novel biopolymer-based nanoparticles loaded cream for potential treatment of topical fungal infections

, ORCID Icon, , , ORCID Icon & ORCID Icon
Pages 1090-1099 | Received 25 Apr 2020, Accepted 25 May 2021, Published online: 06 Aug 2021

References

  • Verma S, Verma G, Sharma V, et al. Current spectrum of dermatophytosis in a tertiary care hospital of North India – a 6-year clinico-mycological study. J Med Sci Clin Res. 2017;5(3):19488–19494.
  • Zhan P, Liu W. The changing face of dermatophytic infections worldwide. Mycopathologia. 2017;182(1–2):77–86.
  • Gupta AK, Foley KA, Versteeg SG. New antifungal agents and new formulations against dermatophytes. Mycopathologia. 2017;182(1–2):127–141.
  • Gupta AK, Cooper EA. Update in antifungal therapy of dermatophytosis. Mycopathologia. 2008;166(5–6):353–367.
  • Durdu M, Ilkit M, Tamadon Y, et al. Topical and systemic antifungals in dermatology practice. Expert Rev Clin Pharmacol. 2017;10(2):225–237.
  • Singh R, Lillard JW. Nanoparticle-based targeted drug delivery. Exp Mol Pathol. 2009;86(3):215–223.
  • Chen HY, Fang JY. Therapeutic patents for topical and transdermal drug delivery systems. Exp Opin Ther Pat. 2000;10(7):1035–1043.
  • Singh M, Gangwar N, Parashar P, et al. Topical delivery of fluconazole via microemulsion incorporated hydrogel for the management of fungal dermatophytosis. Curr Drug Ther. 2016;11(2):129–141.
  • Gupta AK, Chow M, Daniel CR, et al. Treatments of tinea pedis. Dermatol Clin. 2003;21(3):431–462.
  • Gupta M, Agrawal U, Vyas SP. Nanocarrier-based topical drug delivery for the treatment of skin diseases. Expert Opin Drug Deliv. 2012;9(7):783–804.
  • Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces. 2010;75(1):1–18.
  • Qindeel M, Ahmed N, Khan GM, et al. Ligand decorated chitosan as an advanced nanocarrier for targeted delivery: a critical review. Nanomedicine. 2019;14(12):1623–1642.
  • Khan D, Qindeel M, Ahmed N, et al. Development of novel pH-sensitive nanoparticle-based transdermal patch for management of rheumatoid arthritis. Nanomedicine. 2020;15(6):603–624.
  • Wang K, Lin S, Nune K, et al. Chitosan-gelatin-based microgel for sustained drug delivery. J Biomater Sci Polym Ed. 2016;27(5):441–453.
  • Bodnar M, Hartmann JF, Borbely J. Preparation and characterization of chitosan-based nanoparticles. Biomacromolecules. 2005;6(5):2521–2527.
  • Wu D, Zhu L, Li Y, et al. Chitosan-based colloidal polyelectrolyte complexes for drug delivery: a review. Carb Polym. 2020;238:116126.
  • Lefnaoui S, Moulai-Mostefa N, Yahoum MM, et al. Design of antihistaminic transdermal films based on alginate–chitosan polyelectrolyte complexes: characterization and permeation studies. Drug Dev Ind Pharm. 2018;44(3):432–443.
  • Ni Y, Tang Z, Cao W, et al. Tough and elastic hydrogel of hyaluronic acid and chondroitin sulfate as potential cell scaffold materials. Int J Biol Macromol. 2015;74:367–375.
  • Fajardo AR, Fávaro SL, Rubira AF, et al. Dual-network hydrogels based on chemically and physically crosslinked chitosan/chondroitin sulfate. React Funct Polym. 2013;73(12):1662–1671.
  • Coneac G, Vlaia V, Olariu I, et al. Development and evaluation of new microemulsion-based hydrogel formulations for topical delivery of fluconazole. AAPS PharmSciTech. 2015;16(4):889–904.
  • Mitkari B, Korde S, Mahadik K, et al. Formulation and evaluation of topical liposomal gel for fluconazole. Indian J Pharm Educ Res. 2010;44:324–333.
  • Lalit SK, Panwar AS, Darwhekar G, et al. Formulation and evaluation of fluconazole amphiphilogel. Der Pharm Lett. 2011;3:125–131.
  • Abdelmalak NS, El-Menshawe SF. A new topical fluconazole microsponge loaded hydrogel: preparation and characterization. Int J Pharm Pharm Sci. 2012;4:460–468.
  • Tornio A, Niemi M, Neuvonen PJ, et al. Drug interactions with oral antidiabetic agents: pharmacokinetic mechanisms and clinical implications. Trends Pharmacol Sci. 2012;33(6):312–322.
  • Jardim KV, Joanitti GA, Azevedo RB, et al. Physico-chemical characterization and cytotoxicity evaluation of curcumin loaded in chitosan/chondroitin sulfate nanoparticles. Mater Sci Eng C Mater Biol Appl. 2015;56:294–304.
  • Alihosseini F, Ghaffari S, Dabirsiaghi AR, et al. Freeze-drying of ampicillin solid lipid nanoparticles using mannitol as cryoprotectant. Braz J Pharm Sci. 2015;51(4):797–802.
  • Lee MK, Kim MY, Kim S, et al. Cryoprotectants for freeze drying of drug nano-suspensions: effect of freezing rate. J Pharm Sci. 2009;98(12):4808–4817.
  • Al-Hussein A, Gieseler H. The effect of mannitol crystallization in mannitol–sucrose systems on LDH stability during freeze-drying. J Pharm Sci. 2012;101(7):2534–2544.
  • Qindeel M, Ahmed N, Shah KU, et al. New, environment friendly approach for synthesis of amphiphilic PCL–PEG–PCL triblock copolymer: an efficient carrier for fabrication of nanomicelles. J Polym Environ. 2020;28:1237–1251.
  • Zandi G, Lotfipour F, Ghanbarzadeh S, et al. A comparative study on the potentials of nanoliposomes and nanoethosomes for fluconazole delivery. J Drug Deliv Sci Technol. 2018;44:264–269.
  • Qindeel M, Khan D, Ahmed N, et al. Surfactant-free, self-assembled nanomicelles-based transdermal hydrogel for safe and targeted delivery of methotrexate against rheumatoid arthritis. ACS Nano. 2020;14:4662–4681.
  • Salerno C, Carlucci AM, Bregni C. Study of in vitro drug release and percutaneous absorption of fluconazole from topical dosage forms. AAPS PharmSciTech. 2010;11(2):986–993.
  • Qindeel M, Ahmed N, Sabir F, et al. Development of novel pH-sensitive nanoparticles loaded hydrogel for transdermal drug delivery. Drug Dev Ind Pharm. 2019;45(4):629–641.
  • Ramasamy T, Tran TH, Cho HJ, et al. Chitosan-based polyelectrolyte complexes as potential nanoparticulate carriers: physicochemical and biological characterization. Pharm Res. 2014;31(5):1302–1314.
  • Müller M. Sizing, shaping and pharmaceutical applications of polyelectrolyte complex nanoparticles. In: Polyelectrolyte complexes in the dispersed and solid state II. India: Springer; 2012. p. 197–260.
  • Wu D, Ensinas A, Verrier B, et al. Zinc-stabilized chitosan–chondroitin sulfate nanocomplexes for HIV-1 infection inhibition application. Mol Pharm. 2016;13(9):3279–3291.
  • Abdullah TA, Ibrahim NJ, Warsi MH. Chondroitin sulfate–chitosan nanoparticles for ocular delivery of bromfenac sodium: improved permeation, retention, and penetration. Int J Pharm Investig. 2016;6(2):96.
  • Gul R, Ahmed N, Ullah N, et al. Biodegradable ingredient-based emulgel loaded with ketoprofen nanoparticles. AAPS Pharm Sci. 2018;19(4):1869–1881.
  • Maravajhala V, Dasari N, Sepuri A, et al. Design and evaluation of niacin microspheres. Indian J Pharm Sci. 2009;71(6):663–669.
  • Santo VE, Duarte ARC, Gomes ME, et al. Hybrid 3D structure of poly(d,l-lactic acid) loaded with chitosan/chondroitin sulfate nanoparticles to be used as carriers for biomacromolecules in tissue engineering. J Super Fluids. 2010;54(3):320–327.
  • Tsai HY, Chiu CC, Lin PC, et al. Antitumor efficacy of doxorubicin released from crosslinked nanoparticulate chondroitin sulfate/chitosan polyelectrolyte complexes. Macromol Biosci. 2011;11(5):680–688.
  • Yeh MK, Cheng K, Hu CS, et al. Novel protein-loaded chondroitin sulfate–chitosan nanoparticles: preparation and characterization. Acta Biomater. 2011;7(10):3804–3812.
  • Hasan AS, Socha M, Lamprecht A, et al. Effect of the microencapsulation of nanoparticles on the reduction of burst release. Int J Pharm. 2007;344(1–2):53–61.
  • Yien L, Zin NM, Sarwar A, et al. Antifungal activity of chitosan nanoparticles and correlation with their physical properties. Int J Biomater. 2012;2012:1–9.
  • Adebowale A, Cox D, Liang Z, et al. Analysis of glucosamine and chondroitin sulfate content in marketed products and the Caco-2 permeability of chondroitin sulfate raw materials. J Am Nutraceut Assoc. 2000;3:37–44.
  • Charrouf Z, Guillaume D. Argan oil: occurrence, composition and impact on human health. Eur J Lipid Sci Technol. 2008;110(7):632–636.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.